LOS ANGELES, CA. (March 21, 2022) - The Premier Lacrosse League (PLL) powered by Ticketmaster announced today that the league will partner with Q30 Innovations to raise awareness and promote adoption of the Q-Collar, an FDA-authorized device that provides athletes with an added layer of brain protection. As part of the partnership, Q30 will equip athletes across all eight PLL teams with the Q-Collar.

“The PLL is committed to player health and safety. We’re always looking for new ideas to protect our athletes and extend their playing careers,” said Co-Founder and CEO Michael Rabil. “We’re proud to be the first professional sports league partnering with Q30 Innovations, whose Q-Collar is research-backed, safe, and effective.”

Michael Sowers (Waterdogs LC), Jesse Bernhardt (Chrome LC), Marcus Holman (Archers LC), and Jack Rowlett (Chaos LC) have already added the Q-Collar to their roster of protective equipment. “The Q-Collar has given me the confidence to play like myself again knowing it is helping keep my brain protected – I won’t step on the field without it,” said Waterdogs LC attackman Michael Sowers, who started wearing the Q-Collar in 2021.

“After an in-depth review of the studies behind the Q-Collar, I’m confident that the Q-Collar offers our athletes a safe and added protection against those cumulative, repetitive head impacts so common in all contact sports,” said Dr. Catherine Logan, MD, MBA, Head League Physician, Premier Lacrosse League. “The Q-Collar is a welcome new innovation to help keep our players safe.”

“We are extremely excited to be working with the PLL and the best players in the game to bring player safety to the forefront of lacrosse,” said Tom Hoey, Co-CEO of Q30 Innovations, “The PLL’s commitment to innovation, the high standards they have for the league, their partners’ brands, and an incredibly engaged fanbase all make this the ideal partnership for Q30 and the Q-Collar.” 

In February 2021, the FDA authorized the marketing of the Q-Collar to help protect athletes’ brains during head impacts. The FDA clearance was based on a thorough review of 10 years of research conducted independently by leading medical and research institutions across North America. As reported by the FDA, advanced imaging showed no significant changes in deeper tissues of the brain (white matter regions) in 77% of the group of athletes who wore the Q-Collar, while significant changes in these regions were found in 73% of participants in the non-Collar group. The Q-Collar provides an added layer of protection for athletes aged 13 years and older.

The 2022 PLL season will include 14 tour stops from June to September. For more information about the 2022 PLL season, visit www.premierlacrosseleague.com/schedule.

ABOUT PREMIER LACROSSE LEAGUE 

The Premier Lacrosse League (PLL) powered by Ticketmaster is a men’s professional lacrosse league in North America, composed of 8 teams rostered with the best players in the world. Co-founded by lacrosse superstar, philanthropist, and investor Paul Rabil and his brother, serial entrepreneur and investor, Mike Rabil, the Premier Lacrosse League is backed by an investment group composed of Joe Tsai Sports, Brett Jefferson Holdings, The Raine Group, Creative Artists Agency (CAA), Chernin Group, Blum Capital, The Kraft Group, Arctos Sports Partners, and other top investors in sports and media. The PLL was named Sports Breakthrough of the Year in 2020 by the Sports Business Journal. In December 2020, the PLL and Major League Lacrosse (MLL) announced a merger with subsequent season operations and activities to formally exist under the PLL. For more information, visit www.premierlacrosseleague.com and follow on social media: Instagram (@PLL), Twitter (@PremierLacrosse), Facebook (@PremierLacrosseLeague), YouTube (YouTube.com/PLL) and TikTok (@pll).

ABOUT Q30

Since 2012, Q30 has worked with leading medical and academic institutions to research and develop the Q-Collar. Over 25 pre-clinical and clinical studies show the Q-Collar safely and effectively helps protect the brain from effects of repetitive head impacts. The Q-Collar received FDA authorization in February 2021, and officially launched in the United States in September 2021. The Q-Collar is now available for athletes ages 13 and older who are at risk of brain injury during contact sports. For more details, visit qcollar.com and follow on social media: Instagram (@qcollarofficial), Twitter (@qcollarofficial) and Facebook (@qcollarofficial).